A novel algorithm for lung adenocarcinoma based on N6 methyladenosine‐related immune long noncoding RNAs as a reliable biomarker for predicting survival outcomes and selecting sensitive anti‐tumor therapies

BACKGROUND: Lung cancer is a highly heterogeneous malignant tumor with high incidence and mortality. Recently, increasing evidence has demonstrated that N6‐methyladenosine (m6A) methylation and the tumor microenvironment (TME) play important roles in the occurrence and development of lung adenocarci...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Qiuwen, Hu, Bingchuan, Chen, Hang, Zhu, Linwen, Lyu, Yao, Qian, Dingding, Shao, Guofeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459339/
https://www.ncbi.nlm.nih.gov/pubmed/35949000
http://dx.doi.org/10.1002/jcla.24636

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459339/
https://www.ncbi.nlm.nih.gov/pubmed/35949000
http://dx.doi.org/10.1002/jcla.24636

Ejemplares similares